<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37604249</PMID><DateCompleted><Year>2024</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2024</Year><Month>08</Month><Day>21</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2320-2890</ISSN><JournalIssue CitedMedium="Internet"><Volume>47</Volume><Issue>3</Issue><PubDate><Year>2024</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Biomedical journal</Title><ISOAbbreviation>Biomed J</ISOAbbreviation></Journal><ArticleTitle>Acquired Immune Deficiency Syndrome correlation with SARS-CoV-2 N genotypes.</ArticleTitle><Pagination><StartPage>100650</StartPage><MedlinePgn>100650</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100650</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.bj.2023.100650</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S2319-4170(23)00087-2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Epigenetics and clinical observations referring to Betacoronavirus lead to the conjecture that Sarbecovirus may have the ability to infect lymphocytes using a different way than the spike protein. In addition to inducing the death of lymphocytes, thus drastically reducing their population and causing a serious immune deficiency, allows it to remain hidden for long periods of latency using them as a viral reservoir in what is named Long-Covid Disease. Exploring possibilities, the hypothesis is focused on that N protein may be the key of infecting lymphocytes.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">The present article exhibits a computational assay for the latest complete sequences reported to GISAID, correlating N genotypes with an enhancement in the affinity of the complex that causes immune deficiency in order to determine a good docking with the N protein and some receptors in lymphocytes.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A novel high-interaction coupling of N-RBD and CD147 is presented as the main way of infecting lymphocytes, allowing to define those genotypes involved in their affinity enhancement.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The hypothesis is consistent with the mutagenic deriving observed on the in-silico assay, which reveals that genotypes N/120 and N/152 are determinant to reduce the Immune Response of the host infecting lymphocytes, allowing the virus persists indefinitely and causing an Acquire Immune Deficiency Syndrome.</AbstractText><CopyrightInformation>&#xa9; 2023 The Authors. Published by Elsevier B.V. on behalf of Chang Gung University. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ximeno-Rodr&#xed;guez</LastName><ForeName>I&#xf1;igo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ixilka Biotech S.L, Bizkaia, Spain. Electronic address: researcharea@ixilka.net.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanco-delR&#xed;o</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Ixilka Biotech S.L, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astigarraga</LastName><ForeName>Egoitz</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Research and Development Department, IMG Pharma Biotech S.L, Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barreda-G&#xf3;mez</LastName><ForeName>Gabriel</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Research and Development Department, IMG Pharma Biotech S.L, Derio, Bizkaia, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>08</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Biomed J</MedlineTA><NlmUniqueID>101599820</NlmUniqueID><ISSNLinking>2319-4170</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000086462">Coronavirus Nucleocapsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C000705834">nucleocapsid phosphoprotein, SARS-CoV-2</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D010750">Phosphoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="Y">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000163" MajorTopicYN="N">Acquired Immunodeficiency Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086462" MajorTopicYN="N">Coronavirus Nucleocapsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062105" MajorTopicYN="N">Molecular Docking Simulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D010750" MajorTopicYN="N">Phosphoproteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">AIDS</Keyword><Keyword MajorTopicYN="N">Acquired Immune Deficiency Syndrome</Keyword><Keyword MajorTopicYN="N">Artificial intelligence</Keyword><Keyword MajorTopicYN="N">Bioinformatics</Keyword><Keyword MajorTopicYN="N">Long-Covid disease</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>12</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>6</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>8</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>1</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>22</Day><Hour>0</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>21</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>8</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37604249</ArticleId><ArticleId IdType="pmc">PMC11332989</ArticleId><ArticleId IdType="doi">10.1016/j.bj.2023.100650</ArticleId><ArticleId IdType="pii">S2319-4170(23)00087-2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wong Raymond SM, Wu Alan, To KF, Lee Nelson, Lam Christopher WK. Wong CK, et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. Br Med J. 2003;326(7403):1358&#x2013;1362.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC162124</ArticleId><ArticleId IdType="pubmed">12816821</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z,et al. Clinical course and risk factors for mortality of adult inpatients with covid-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Jafarzadeh A, Jafarzadeh S, Nozari P, Mokhtari P, Nemati M. Lymphopenia an important immunological abnormality in patients with covid-19: possible mechanisms. Scand J Immunol. 2021;93(2)</Citation><ArticleIdList><ArticleId IdType="pubmed">32875598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lamontagne Lucie, Descoteaux JP, Jolicoeur Pierre. Mouse hepatitis virus 3 replication in t and b lymphocytes correlate with viral pathogenicity. J Immunol. 1989;142(12):4458&#x2013;4465.</Citation><ArticleIdList><ArticleId IdType="pubmed">2542412</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo P, Mur I, Pomar V, Corominas H, Casademont J, de Benito N. The four horsemen of a viral apocalypse: the pathogenesis of sars-cov-2 infection (covid-19) EBioMedicine. 2020;58</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387269</ArticleId><ArticleId IdType="pubmed">32736307</ArticleId></ArticleIdList></Reference><Reference><Citation>Wan S, Yi Q, Fan S, Lv J, Zhang X, Guo L, et al. Relationships among lymphocyte subsets, cytokines, and the pulmonary inflammation index in coronavirus (covid-19) infected patients. Br J Haematol. 2020;189(3):428&#x2013;437.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262036</ArticleId><ArticleId IdType="pubmed">32297671</ArticleId></ArticleIdList></Reference><Reference><Citation>Maeda K, Malykhin A, Teague-Weber BN, Sun XH, Farris AD, Coggeshall KM. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus&#x2013;prone B6.Sle1.Yaa animals. Blood. 2009;113(19):4534&#x2013;4540.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2680362</ArticleId><ArticleId IdType="pubmed">19224760</ArticleId></ArticleIdList></Reference><Reference><Citation>Channappanavar R, Perlman S. Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology. Semin Immunopathol. 2017;39(5):529-39</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7079893</ArticleId><ArticleId IdType="pubmed">28466096</ArticleId></ArticleIdList></Reference><Reference><Citation>Masi&#xe1; Mar, Fern&#xe1;ndez-Gonz&#xe1;lez M, Garc&#xed;a JA, Padilla S, Garc&#xed;a-Abell&#xe1;n J Botella &#xc1;ngela, et al. Robust long-term immunity to SARS-CoV-2 in patients recovered from severe COVID-19 after interleukin-6 blockade. EBioMedicine. 2022;82:104153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9265168</ArticleId><ArticleId IdType="pubmed">35816896</ArticleId></ArticleIdList></Reference><Reference><Citation>Aubrey BJ, Kelly GL, Janic A, Herold MJ, Strasser A. How does P53 induce apoptosis and how does this relate to P53-mediated tumour suppression? Cell Death Differ. 2018;25(1):103&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5729529</ArticleId><ArticleId IdType="pubmed">29149101</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricke D O. Two different Antibody-Dependent Enhancement (ADE) risks for SARS-CoV-2 antibodies. Front Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943455</ArticleId><ArticleId IdType="pubmed">33717193</ArticleId></ArticleIdList></Reference><Reference><Citation>Brunetti NS, Davanzo GG, de Moraes D, Ferrari AJR, Souza GF, et al. SARS-CoV-2 uses CD4 to infect T helper lymphocytes. Elife. 2023;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10390044</ArticleId><ArticleId IdType="pubmed">37523305</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Ejikemeuwa A, Gerzanich V, Nasr M, Tang Q, Simard JM, et al. Understanding the role of SARS-CoV-2 ORF3a in viral pathogenesis and COVID-19. Front Microbiol. 2022;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8959714</ArticleId><ArticleId IdType="pubmed">35356515</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen IY, Miyu Moriyama, Chang MF, Takeshi Ichinohe. Severe acute respiratory syndrome coronavirus viroporin 3a activates the NLRP3 inflammasome. Front Microbiol. 2019;10:50</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6361828</ArticleId><ArticleId IdType="pubmed">30761102</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang M, Chang W, Zhang L, Zhang Y. Pyroptotic cell death in sars-cov-2 infection: revealing its roles during the immunopathogenesis of covid-19. Int J Biol Sci. 2022;18(15):5827&#x2013;5848.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9576507</ArticleId><ArticleId IdType="pubmed">36263178</ArticleId></ArticleIdList></Reference><Reference><Citation>Yilla M, Harcourt BH, HickMan CJ, McGrew M, Tamin A, Goldsmith C S., et al. SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Res. 2005;107(1):93&#x2013;101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114182</ArticleId><ArticleId IdType="pubmed">15567038</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzikowska U, Ding M, Tan G, Zhakparov D, Peng Y, Wawrzyniak P, et al. Distribution of ACE2, CD147, CD26, and other SARS-CoV-2 associated molecules in tissues and immune cells in health and in asthma, copd, obesity, hypertension, and COVID-19 risk factors. Allergy. 2020;75(11):2829&#x2013;2845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300910</ArticleId><ArticleId IdType="pubmed">32496587</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen XR, Geng R, Li Q, Chen Y, Li SF, Wang Q, et al. ACE2-independent infection of T lymphocytes by SARS-CoV-2. Signal Transduct Target Ther. 2022;7(1):83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8914143</ArticleId><ArticleId IdType="pubmed">35277473</ArticleId></ArticleIdList></Reference><Reference><Citation>Bermejo-Vald&#xe9;s AJ, Cervera-Grau JM. Lighting up dark areas of COVID-19. Ann Case Report. 2020;14:394.</Citation></Reference><Reference><Citation>Helal M A, Shouman S, Abdelwaly A, Elmehrath A O. Essawy M, Sayed SM, et al. Molecular basis of the potential interaction of SARS-CoV-2 spike protein to CD147 in COVID-19 associated-lymphopenia. J Biomol Struct Dyn. 2022;40(3):1109&#x2013;1119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7544927</ArticleId><ArticleId IdType="pubmed">32936048</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x141;acina P, Butrym A, Turlej E, Stachowicz-Suhs M, Wietrzyk J, Mazur G, et al. BSG (CD147) serum level and genetic variants are associated with overall survival in acute myeloid leukaemia. J Clin Med. 2022;11(2):332.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8779396</ArticleId><ArticleId IdType="pubmed">35054026</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang-Du Hospital. Clinical study of anti-CD147 humanized meplazumab for injection to treat with 2019-nCoV pneumonia. https://clinicaltrials.gov/study/NCT04275245</Citation></Reference><Reference><Citation>GISAID (Global Initiative on Sharing All Influenza Data),https://gisaid.org/.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5388101</ArticleId><ArticleId IdType="pubmed">28382917</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics. 2018;34(23):4121-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6247931</ArticleId><ArticleId IdType="pubmed">29790939</ArticleId></ArticleIdList></Reference><Reference><Citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, et al. The Protein Data Bank. Nucleic Acids Res. 2000;28(1):235-42.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC102472</ArticleId><ArticleId IdType="pubmed">10592235</ArticleId></ArticleIdList></Reference><Reference><Citation>European Centre for Disease Prevention and Control. Sources - Worldwide data on COVID-19, https://www.ecdc.europa.eu/en/publications-data/sources-worldwide-data-covid-19.</Citation></Reference><Reference><Citation>Jurrus E, Engel D, Star K, Monson K, Brandi J, Felberg LE, et al. Improvements to the APBS biomolecular solvation software suite. Protein Sci. 2018;27(1):112&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5734301</ArticleId><ArticleId IdType="pubmed">28836357</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirdita M, Sch&#xfc;tze K, Moriwaki Y, Heo L, Ovchinnikov S, Steinegger M. ColabFold: making protein folding accessible to all.Nat Methods. 2022 ;19(6):679-82.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9184281</ArticleId><ArticleId IdType="pubmed">35637307</ArticleId></ArticleIdList></Reference><Reference><Citation>AlphaFold - DeepMind, https://deepmind.google/technologies/alphafold/.</Citation></Reference><Reference><Citation>Klett J, N&#xfa;&#xf1;ez-Salgado A, Dos Santos HG, Cort&#xe9;s-Cabrera &#xc1;, Perona A, Gil-Redondo R, et al. MM-ISMSA: an ultrafast and accurate scoring function for protein&#x2013;protein docking. J Chem Theory Comput. 2012;8(9):3395&#x2013;3408.</Citation><ArticleIdList><ArticleId IdType="pubmed">26605745</ArticleId></ArticleIdList></Reference><Reference><Citation>Schr&#xf6;dinger, LLC.  The PyMOL molecular graphics system. https://pymol.org/support.html version 2.4.</Citation></Reference><Reference><Citation>Khan A, Khan S, Shoaib S, Nizam-Uddin N, Mohammad A Khan T, et al. Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation. Comput Biol Med. 2021;133:104420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064902</ArticleId><ArticleId IdType="pubmed">33930764</ArticleId></ArticleIdList></Reference><Reference><Citation>Popper KR. R.Die beiden Grundprobleme der Erkenntnistheorie. German : Mohr Siebeck; 1979.</Citation></Reference><Reference><Citation>Ximeno-Rodr&#xed;guez I&#xf1;igo, Gil-Edwards Sara, Mera-Cordero Francisco, March-Villalba Jose A, Rodrigo Abad-Rodr&#xed;guez, et al. 2022. Genotype S/493Q omicron - emerging variant of high biological risk.</Citation><ArticleIdList><ArticleId IdType="doi">10.13140/RG.2.2.27602.89282</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan A, Zia T, Muhammad M, Khan T, Ali SS, Abbasi AA, et al. Higher infectivity of the sars-cov-2 new variants is associated with k417n/t, e484k, and n501y mutants: an insight from structural data. J Cell Physiol. 2021;236(10):7045&#x2013;7057.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251074</ArticleId><ArticleId IdType="pubmed">33755190</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang ZY, Werner HC, Kong WP, Leung K, Traggiai E, et al. Evasion of antibody neutralization in emerging severe acute respiratory syndrome coronaviruses. Proc Natl Acad Sci U S A. 2005;102(3):797&#x2013;801.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC545557</ArticleId><ArticleId IdType="pubmed">15642942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaunt ER, Hardie A., Claas EC, Simmonds P, Templeton KE. Epidemiology and clinical presentations of the four human coronaviruses 229E, HKU1, NL63, and OC43 detected over 3 years using a novel multiplex real-time PCR method. J Clin Microbiol. 2010;48(8):2940&#x2013;2947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2916580</ArticleId><ArticleId IdType="pubmed">20554810</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu DX, JQ Liang., TS Fung. In: Encyclopedia of virology. 4th ed. Bamford D.H., Zuckerman M., editors. Academic Press; Oxford: 2021. Human Coronavirus-229E, -OC43, -NL63, and -HKU1 (coronaviridae) pp. 428&#x2013;440.</Citation></Reference><Reference><Citation>Hulswit R JG, Lang Y, Bakkers M JG, Li W, Li Z, Schouten A, et al. Human coronaviruses OC43 and HKU1 bind to 9-O-acetylated sialic acids via A conserved receptor-binding site in spike protein domain a. Proc Natl Acad Sci U S A. 2019;116(7):2681&#x2013;2690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6377473</ArticleId><ArticleId IdType="pubmed">30679277</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanwar A, Selvaraju S, Esper F. Human Coronavirus-HKU1 infection among adults in Cleveland, Ohio. Open Forum Infect Dis. 2017;4(2):ofx052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5466428</ArticleId><ArticleId IdType="pubmed">28616442</ArticleId></ArticleIdList></Reference><Reference><Citation>Woo P C., Lau S K, Yip C C, Huang Y, Tsoi HW., Chang Kwok-Hung, et al. Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J Virol. 2006;80(14):7136&#x2013;7145.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1489027</ArticleId><ArticleId IdType="pubmed">16809319</ArticleId></ArticleIdList></Reference><Reference><Citation>Beretta A, Cranage M, Zipeto D. Is cross-reactive immunity triggering COVID-19 immunopathogenesis? Front Immunol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7594548</ArticleId><ArticleId IdType="pubmed">33178193</ArticleId></ArticleIdList></Reference><Reference><Citation>Fierz W, Walz B. Antibody Dependent Enhancement due to Original Antigenic Sin and the development of SARS. Front Immunol. 2020;11:1120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7291596</ArticleId><ArticleId IdType="pubmed">32582200</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekliz M, Adea K, Puhach O, Perez-Rodriguez F, Marques Melancia S, Baggio S, et al. Analytical sensitivity of eight different SARS-CoV-2 Antigen-Detecting rapid tests for Omicron-BA.1 variant. Microbiol Spectr. 2022;10(4)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9430749</ArticleId><ArticleId IdType="pubmed">35938792</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>